JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event

Multiple Sclerosis

Volumn 13, Issue 5, 2007, Pages 590-595

  Álvarez Lafuente, Roberto ^a   Garvía Montojo, Marta ^a   De Las Heras, Virginia ^a   Bartolomé, Manuel ^a   Arroyo, Rafael ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

CSF; JCV; Multiple sclerosis; Quantitative PCR

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DNA DETERMINATION; DNA EXTRACTION; FEMALE; FOLLOW UP; HUMAN; JC VIRUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; SEROPREVALENCE; VIRUS GENOME; VIRUS LOAD; VIRUS PARTICLE; VIRUS PATHOGENESIS;

ADULT; DEMYELINATING DISEASES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; JC VIRUS; MALE; MULTIPLE SCLEROSIS; POLYOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 34250630506     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506073116     Document Type: Article

References (33)

1. Kwak EJ, Vilchez RA, Randhawa P, Shapiro R, Butel JS, Kusne S. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis 2002; 35: 1081-87.
2. Dorries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand 1998; 94: 71-79.
3. Ferrante P, Omodeo-Zorini E, Caldarelli-Stefano R, Mediati M, Fainardi E, Granieri E et al. Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 1998; 4: 49-54.
4. Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand Suppl 1995; 161: 23-33.
5. Wolfson C. Multiple sclerosis and antecedent infections. Epidemiology 2001; 12: 298-99.
6. Gordon J, Khalili K. The human polyomavinis, JCV, and neurological diseases. Int J Mol Med 1998; 1: 647-55.
7. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369-74.
8. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375-81.
9. Mischitelli M, Fioriti D, Videtta M, Degener M, Antinori A, Cinque P et al. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 2005; 204: 913-18.
10. Watzinger F, Suda M, Preuner S, Batungartinger R, Ebner K, Baskova L et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol 2004; 42: 5189-98.
11. Frisque RJ, White FA. The molecular biology of JC virus, causative agent of progressive multifocal leukoen-cephalopathy. In Roos RP ed. Molecular neurovirology. Humana Press Inc., 1992: 25-158.
12. Berger JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 2003; 9: 38-41.
13. Kitamura T, Sugimoto C, Kato A, Ebihara H, Suzuki M, Taguchi F et al. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol 1997; 35: 1255-57.
14. Tominaga T, Yogo Y, Kitamura T, Aso Y. Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients. Virology 1992; 186: 736-41.
15. Hori R, Murai Y, Tsuneyama K, Abdel-Aziz HO, Nomoto K, Takahashi H et al. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch 2005; 447: 723-30.
16. Dubois V, Lafon ME, Ragnaud JM, Pellegrin JL, Damasio F, Baudouin C et al. Detection of JC virus DNA in the peripheral blood leukocytes of HIV-infected patients. AIDS 1996; 10: 353-58.
17. Del Valle L, Enam S, Lara C, Miklossy J, Khalili K, Gordo J. Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol 2004; 78: 3462-69.
18. Ricciardiello L, Laghi L, Ramamirtham P, Chang CL, Chang DK, Randolph AE et al. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 2000; 119: 1228-35.
19. Rencic A, Gordon J, Otte J, Curtis M, Kovatich A, Zoltick P et al. Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma. Proc Natl Acad Sci U S A 1996; 93: 7352-57.
20. Yousry TA, Major EO, Ryschkewitsch C, Fable G, Fischer S, Hou J et al. Evaluation of patients treated with Natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924-33.
21. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM, Bonington A. BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection 2003; 31: 374-78.
22. Eggers C, Stellbrink HJ, Buhk T, Dorries K. Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy - a longitudinal study. J Inrect Dis 1999; 180: 1690-94.
23. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52: 253-60.
24. Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J et al. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 1999; 45: 816-21.
25. Garcia De Viedma D, Diaz lnfantes M, Miralles P, Berenguer J, Marin M, Munoz L et al. JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions. Clin Inrect Dis 2002; 34: 1568-75.
26. Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M et al. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005; 40: 738-44.
27. Rotola A, Merlotti I, Caniatti L, Caselli E, Granieri E, Tola MR et al. Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler 2004; 10: 348-54.
28. Maggi F, Fornai C, Vatteroni ML, Siciliano G, Menichetti F, Tascini C et al. Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders. J Med Virol 2001; 65: 418-22.
29. Tejada-Simon MV, Zang YCO, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002; 76: 6147-54.
30. Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult Scler 1998; 4: 490-96.
31. Puccioni-Sohler M, Rios M, Carvalho SN, Goncalves RR, Oliveira C, Correa RB et al. Diagnosis of HAM/TSP based on CSF proviral HTLV-1 DNA and HTLV-1 antibody index. Neurology 2001; 57: 725-27.
32. Achiron A, Miron S, Shoenfeld Y. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas? The JC virus story in multiple sclerosis. Isr Med Assoc J 2005; 7: 283-85.
33. Stoner GL. Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS. Acta Neurol Scand 1991; 83: 20-33.